Nosocomial fungaemia: A 2-year prospective study

Journal of Hospital Infection

Volumn 45, Issue 1, 2000, Pages 69-72

  Costa, S F ^a   Marinho, I ^a   Arauujo E A P ^a   Manrique, A E I ^a   Medeiros, E A S ^a   Levin, A S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Fungemia; Nosocomial infections; Survival

Indexed keywords

AMPHOTERICIN; IMIPENEM; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CHILD; FEMALE; FUNGEMIA; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HOSPITAL INFECTION; HUMAN; INFANT; INTRAVENOUS CATHETER; MAJOR CLINICAL STUDY; MALE; NEWBORN; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SURVIVAL;

EID: 0034089656     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhin.1999.0670     Document Type: Article

References (20)

1. Beck-Sague C. M., Jarvis W. R. National Nosocomial infections Surveillance System. Secular trends in the epidemiology of nosocomial states: 1980-90. J Infect Dis. 167:1993;1247-1251.
2. Edwards J. E. J. R. Invasive Candida infections: evolution of a fungal pathogen. N Engl J Med. 324:1991;1060-1062.
3. Fraser V. J., Jones M., Dunkel. Candidemia in a tertiary care hospital; Epidemiology, risk factors, and predictors of mortality. Clin Infect Dis. 15:1992;414-421.
4. Harvery R. L., Myers P. J. Nosocomial fungemia in a large community hospital. Arch Intern Med. 147:1987;2117-2120.
5. Nguyen M. H., Peacock J. E., Morris A. J. The chaging face of candidemia: emergence of non- Candida albicans species and antifungal resistance. Am J med. 100:1996;617-623.
6. Wingard J. R., Merz W. G., Rinaldi M. G. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylaticaly with fluconazole. N Engl J Med. 325:1991;1274-1277.
7. Pfaller M. A., Jones R. N., Messer A. S., Edmond M. B., Wenzel R. P. National Surveillance of Nosocomial blood stream infection due to species Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE participant group. Surveillance and Control of Pathogens of Epidemiology. Diagn Microbiol Infect Dis. 30:1998;: 121-129.
8. Nucci M., Colombo A. L., Silveira F. Risk Factors for death in patients with Candidemia. Infect Control Hosp Epidem. 19:1998;846-850.
9. Price M. F., Laroco M. T., Gentry L. O. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5 year period. Antimicrob Agents Chemotherapy. 38:1994;1422-1424.
10. Anaissie E., Kantarjian H., Ro J. The emerging role of Fusarium infections in patients with Cancer. Medicine. 62:1988;77-83.
11. Braun D. K., Kauffman C. A. Rhodotorula fungaemia: a life-treating complication of indwelling central venous catheter. Mycoses. 35:1992;305-308.
12. Moses A., Maayans S., Shvily S. Hansenula anomala infections in children: from asymptomatic colonization to tissue invasion. Pediatric Infect Dis. 10:1991;400-402.
13. Sekhom A. S., Kowalews K. A., Grochowsk A. K. Hansenula anomala fungemia in an infant with gastric and cardiac complications with a review of the literature. Eur J Epidemiol. 8:1992;305-308.
14. Wright W. L., Wenzel R. P. Nosocomial Candida. Epidemiology; Transmission and Prevention. Infect Dis North Am. 2:1997;411-425.
15. Pfaller M. A., Messer S. A., Hollis R. J. Variations in DNA subtype, antifungal susceptibility, and slime production among isolates of Candida parapsilosis. Diagn Microb Infect Dis. 20:1995;127-133.
16. Wey S. B., Mori M., Pfaller M. A. Hospital-acquired candidemia: the attriburable mortality and excess length of stay. Arch Intern Med. 148:1998;2642-2645.
17. Komshiam S. V., Uwaydah A. K., Sobwl J. D. Fungaemia caused by Candida species and Torulopsis glabrata in the hospitalized patients: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis. 11:1989;379-390.
18. Meunier F., Aoun M., Bitar N. Candidaemia in immunocomproised patients. Clin Infect Dis. 14:1992;: S120-S125.
19. Soub H. A. L., Estioso W. Hospital-acquired Candidemia: experience from a developing country. J Hosp Infect. 35:1997;141-147.
20. Anaissie E. J., Rex J. H., Uzun O., Vartvarian S. Predictors of adverse outcome in cancer patients with candidemia. Am J Med. 104:1998;238-245.